The company’s first quarter ended Aug. 31. During the first quarter last year, Biomet lost $31.5 million.
Sports, extremities and trauma devices brought much of this year’s profit; the segment earned $149.5 million this year, up 17.4 percent from 2012. Knees were also profitable, bringing in $225.1 million or 3.5 percent more than last year.
More Articles on Devices:
X-Stop Spine Surgery: Outcomes Analysis
19 Spine Devices Get FDA 510(k) Clearance in September
Spine Wave Implements iTraycer for Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
